{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:55:23Z","timestamp":1785797723312,"version":"3.56.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study evaluated the effects of local application of autologous platelet-rich plasma (PRP) on the tooth extraction site of rats presenting the main risk factors for medication-related osteonecrosis of the jaw (MRONJ). For seven weeks, senile rats were submitted to systemic treatment with vehicle (VEH and VEH-PRP) or 100\u2009\u03bcg\/Kg of zoledronate (ZOL and ZOL-PRP) every three days. After three weeks, the first lower molar was extracted. VEH-PRP and ZOL-PRP received PRP at the tooth extraction site. Euthanasia was performed at 28 days postoperatively. Clinical, histopathological, histometric and immunohistochemical analyses were carried out in histological sections from the tooth extraction site. ZOL showed lower percentage of newly formed bone tissue (NFBT), higher percentage of non-vital bone tissue (NVBT), as well as higher immunolabeling for TNF\u03b1 and IL-1\u03b2. In addition, ZOL presented lower immunolabeling for PCNA, VEGF, BMP2\/4, OCN and TRAP. VEH and ZOL-PRP showed improvement in the tooth extraction site wound healing and comparable percentage of NFBT, VEGF, BMP2\/4 and OCN. Local application of autologous PRP proved a viable preventive therapy, which is safe and effective to restore tissue repair capacity of the tooth extraction site and prevent the occurrence of MRONJ following tooth extraction.<\/jats:p>","DOI":"10.1038\/s41598-018-37063-y","type":"journal-article","created":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T09:05:06Z","timestamp":1546592706000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Application of Autologous Platelet-Rich Plasma on Tooth Extraction Site Prevents Occurence of Medication-Related Osteonecrosis of the Jaws in Rats"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1049-4257","authenticated-orcid":false,"given":"Luan Felipe","family":"Toro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Martins","family":"de Mello-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Furuse Ventura dos","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia Chaves","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Statkievicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano Tavares \u00c2ngelo","family":"Cintra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Paulo Mardegan","family":"Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita C\u00e1ssia Menegati","family":"Dornelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliano Milanezi","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9 Hitomi","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valdir Gouveia","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia Helena","family":"Theodoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udio Aparecido","family":"Casatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4859-0583","authenticated-orcid":false,"given":"Edilson","family":"Ervolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,10]]},"reference":[{"key":"37063_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bone.2010.11.008","volume":"49","author":"MJ Rogers","year":"2011","unstructured":"Rogers, M. J., Crockett, J. C., Coxon, F. P. & M\u00f6nkk\u00f6nen, J. Biochemical and molecular mechanisms of action of bisphosphonates. Bone. 49, 34\u201341 (2011).","journal-title":"Bone."},{"key":"37063_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bone.2011.01.014","volume":"49","author":"S Cremers","year":"2011","unstructured":"Cremers, S. & Papapoulos, S. Pharmacology of bisphosphonates. Bone. 49, 42\u201349 (2011).","journal-title":"Bone."},{"key":"37063_CR3","doi-asserted-by":"publisher","first-page":"e.321","DOI":"10.4081\/oncol.2017.321","volume":"11","author":"F Macedo","year":"2017","unstructured":"Macedo, F. et al. Bone metastases: an overview. Oncol Rev. 11, e.321 (2017).","journal-title":"Oncol Rev."},{"key":"37063_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.etap.2016.01.015","volume":"42","author":"AP Soares","year":"2016","unstructured":"Soares, A. P. et al. Bisphosphonates: pharmacokinetics, bioavailability, mechanisms of action, clinical applications in children, and effects on tooth development. Environ Toxicol Pharmacol. 42, 212\u2013217 (2016).","journal-title":"Environ Toxicol Pharmacol."},{"key":"37063_CR5","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.4065\/83.9.1032","volume":"83","author":"MT Drake","year":"2008","unstructured":"Drake, M. T., Clarke, B. L. & Khosla, S. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc. 83, 1032\u20131045 (2008).","journal-title":"Mayo Clin Proc."},{"key":"37063_CR6","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1016\/j.joms.2014.08.017","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero, S. L. & Dodson, T. B. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaws - 2014 update. J Oral Maxillofac Surg. 72, 2381\u20132382 (2014).","journal-title":"J Oral Maxillofac Surg."},{"key":"37063_CR7","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","volume":"22","author":"S Khosla","year":"2007","unstructured":"Khosla, S. et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 22, 1479\u20131491 (2007).","journal-title":"J Bone Miner Res."},{"key":"37063_CR8","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/odi.12708","volume":"24","author":"K Mcgowan","year":"2018","unstructured":"Mcgowan, K., Mcgowan, T. & Ivanovski, S. Risk factors for medication-related osteonecrosis of the jaws: a systematic review. Oral Dis. 24, 527\u2013536 (2018).","journal-title":"Oral Dis."},{"key":"37063_CR9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jcms.2011.05.003","volume":"40","author":"S Otto","year":"2012","unstructured":"Otto, S. et al. Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment. J Craniomaxillofac Surg. 40, 303\u2013309 (2012).","journal-title":"J Craniomaxillofac Surg."},{"key":"37063_CR10","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx, R. E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 61, 1115\u20131117 (2003).","journal-title":"J Oral Maxillofac Surg."},{"key":"37063_CR11","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s11914-018-0474-4","volume":"16","author":"J Chang","year":"2018","unstructured":"Chang, J., Hakam, A. E. & McCauley, L. K. Current Understanding of the Pathophysiology of Osteonecrosis of the Jaw. Curr Osteoporos Rep. 16, 584\u2013595 (2018).","journal-title":"Curr Osteoporos Rep."},{"key":"37063_CR12","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.coms.2015.06.001","volume":"27","author":"T Aghaloo","year":"2015","unstructured":"Aghaloo, T., Hazboun, R. & Tetradis, S. Pathophysiology of osteonecrosis of the jaws. Oral Maxillofac Surg Clin North Am. 27, 489\u2013496 (2015).","journal-title":"Oral Maxillofac Surg Clin North Am."},{"key":"37063_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nrendo.2010.195","volume":"7","author":"CA Migliorati","year":"2011","unstructured":"Migliorati, C. A., Epstein, J. B., Abt, E. & Berenson, J. R. Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review. Nat Rev Endocrinol. 7, 34\u201342 (2011).","journal-title":"Nat Rev Endocrinol."},{"key":"37063_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.joms.2009.01.007","volume":"67","author":"MR Allen","year":"2009","unstructured":"Allen, M. R. & Burr, D. B. The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data. J Oral Maxillofac Surg. 67, 61\u201370 (2009).","journal-title":"J Oral Maxillofac Surg."},{"key":"37063_CR15","first-page":"141","volume":"9","author":"EB Berm\u00fadez-Bejarano","year":"2017","unstructured":"Berm\u00fadez-Bejarano, E. B. et al. Prophylaxis and antibiotic therapy in management protocols of patients treated with oral and intravenous bisphosphonates. J Clin Exp Dent. 9, 141\u2013149 (2017).","journal-title":"J Clin Exp Dent."},{"key":"37063_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1601-0825.2011.01848.x","volume":"18","author":"X Ji","year":"2012","unstructured":"Ji, X. et al. Antibiotic effects on bacterial profile in osteonecrosis of the jaw. Oral Dis. 18, 85\u201395 (2012).","journal-title":"Oral Dis."},{"key":"37063_CR17","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.adaj.2017.04.002","volume":"148","author":"M El-Rabbany","year":"2017","unstructured":"El-Rabbany, M., Sgro, A., Lam, D. K., Shah, P. S. & Azarpazhooh, A. Effectiveness of treatments for medication-related osteonecrosis of the jaw: a systematic review and meta-analysis. J Am Dent Assoc. 148, 584\u2013594 (2017).","journal-title":"J Am Dent Assoc."},{"key":"37063_CR18","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1002\/jbmr.3191","volume":"32","author":"S Hayashida","year":"2017","unstructured":"Hayashida, S. et al. Evaluation of the treatment strategies for medication-related osteonecrosis of the jaws (MRONJ) and the factors affecting treatment outcome: a multicenter retrospective study with propensity score matching analysis. J Bone Miner Res. 32, 2022\u20132029 (2017).","journal-title":"J Bone Miner Res."},{"key":"37063_CR19","first-page":"e.CD008455","volume":"2","author":"V Rollason","year":"2016","unstructured":"Rollason, V. et al. Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ). Cochrane Database Syst Rev. 2, e.CD008455 (2016).","journal-title":"Cochrane Database Syst Rev."},{"key":"37063_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.joms.2003.12.003","volume":"62","author":"RE Marx","year":"2004","unstructured":"Marx, R. E. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 62, 489\u2013496 (2004).","journal-title":"J Oral Maxillofac Surg."},{"key":"37063_CR21","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/S1079-2104(98)90029-4","volume":"85","author":"RE Marx","year":"1998","unstructured":"Marx, R. E. et al. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 85, 638\u2013646 (1998).","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod."},{"key":"37063_CR22","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/MOH.0000000000000183","volume":"22","author":"CS Cohn","year":"2015","unstructured":"Cohn, C. S. & Lockhart, E. Autologous platelet-rich plasma: evidence for clinical use. Curr Opin Hematol. 22, 527\u2013532 (2015).","journal-title":"Curr Opin Hematol."},{"key":"37063_CR23","doi-asserted-by":"publisher","first-page":"e.23","DOI":"10.1186\/1742-4933-10-23","volume":"10","author":"A Albanese","year":"2013","unstructured":"Albanese, A., Licata, M. E., Polizzi, B. & Campisi, G. Platelet-rich plasma (PRP) in dental and oral surgery: from the wound healing to bone regeneration. Immun Ageing. 10, e.23 (2013).","journal-title":"Immun Ageing."},{"key":"37063_CR24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3109\/09537104.2012.684730","volume":"24","author":"J Alsousou","year":"2013","unstructured":"Alsousou, J., Ali, A., Willett, K. & Harrison, P. The role of platelet-rich plasma in tissue regeneration. Platelets. 24, 173\u2013182 (2013).","journal-title":"Platelets."},{"key":"37063_CR25","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.injury.2008.06.025","volume":"40","author":"XL Griffin","year":"2009","unstructured":"Griffin, X. L., Smith, C. M. & Costa, M. L. The clinical use of platelet-rich plasma in the promotion of bone healing: a systematic review. Injury. 40, 158\u2013162 (2009).","journal-title":"Injury."},{"key":"37063_CR26","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1600-0501.2008.01525.x","volume":"19","author":"AS Plachokova","year":"2008","unstructured":"Plachokova, A. S., Nikolidakis, D., Mulder, J., Jansen, J. A. & Creugers, N. H. Effect of platelet-rich plasma on bone regeneration in dentistry: a systematic review. Clin Oral Implants Res. 19, 539\u2013545 (2008).","journal-title":"Clin Oral Implants Res."},{"key":"37063_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/jfb9010010","volume":"9","author":"D Chicharro-Alc\u00e1ntara","year":"2018","unstructured":"Chicharro-Alc\u00e1ntara, D. et al. Platelet rich plasma: new insights for cutaneous wound healing management. J Funct Biomater. 9, 10 (2018).","journal-title":"J Funct Biomater."},{"key":"37063_CR28","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1902\/jop.2011.110505","volume":"83","author":"E Anitua","year":"2012","unstructured":"Anitua, E., Troya, M. & Orive, G. Plasma rich in growth factors promote gingival tissue regeneration by stimulating fibroblast proliferation and migration and by blocking transforming growth factor-\u03b21-induced myodifferentiation. J Periodontol. 83, 1028\u20131037 (2012).","journal-title":"J Periodontol."},{"key":"37063_CR29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1089\/ten.teb.2008.0062","volume":"14","author":"D Nikolidakis","year":"2008","unstructured":"Nikolidakis, D. & Jansen, J. A. The biology of platelet-rich plasma and its application in oral surgery: literature review. Tissue Eng Part B Rev. 14, 249\u2013258 (2008).","journal-title":"Tissue Eng Part B Rev."},{"key":"37063_CR30","first-page":"729","volume":"22","author":"OS Petrungaro","year":"2001","unstructured":"Petrungaro, O. S. Using platelet-rich plasma to accelerate soft tissue maturation in esthetic periodontal surgery. Compend Contin Educ Dent. 22, 729\u2013732 (2001).","journal-title":"Compend Contin Educ Dent."},{"key":"37063_CR31","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1902\/jop.2007.060302","volume":"78","author":"H El-Sharkawy","year":"2007","unstructured":"El-Sharkawy, H. et al. Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. J Periodontol. 78, 661\u2013669 (2007).","journal-title":"J Periodontol."},{"key":"37063_CR32","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3109\/09537104.2015.1116686","volume":"27","author":"MD Fabbro","year":"2016","unstructured":"Fabbro, M. D., Bortolin, M., Taschieri, S., Ceci, C. & Weinstein, R. L. Antimicrobial properties of platelet-rich preparations. a systematic review of the current pre-clinical evidence. Platelets. 27, 276\u2013285 (2016).","journal-title":"Platelets."},{"key":"37063_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejca.2014.10.015","volume":"51","author":"M Del Fabbro","year":"2015","unstructured":"Del Fabbro, M., Gallesio, G. & Mozzati, M. Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature. Eur J Cancer. 51, 62\u201374 (2015).","journal-title":"Eur J Cancer."},{"key":"37063_CR34","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jcms.2015.03.039","volume":"43","author":"S Otto","year":"2015","unstructured":"Otto, S. et al. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: a trigger for BRONJ development? J Craniomaxillofac Surg. 43, 847\u2013854 (2015).","journal-title":"J Craniomaxillofac Surg."},{"key":"37063_CR35","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1902\/jop.2013.130017","volume":"85","author":"V Thumbigere-Math","year":"2014","unstructured":"Thumbigere-Math, V. et al. Periodontal disease as a risk factor for bisphosphonate-related osteonecrosis of the jaw. J Periodontol. 85, 226\u2013233 (2014).","journal-title":"J Periodontol."},{"key":"37063_CR36","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.joms.2017.02.009","volume":"75","author":"M Del Fabbro","year":"2017","unstructured":"Del Fabbro, M. et al. Healing of postextraction sockets preserved with autologous platelet concentrates. A systematic review and meta-analysis. J Oral Maxillofac Surg. 75, 1601\u20131615 (2017).","journal-title":"J Oral Maxillofac Surg."},{"key":"37063_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00784-010-0507-6","volume":"16","author":"AM Pabst","year":"2012","unstructured":"Pabst, A. M. et al. The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes-in vitro study. Clin Oral Investig. 16, 87\u201393 (2012).","journal-title":"Clin Oral Investig."},{"key":"37063_CR38","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/j.1600-0714.2012.01173.x","volume":"41","author":"S Saracino","year":"2012","unstructured":"Saracino, S. et al. Exposing human epithelial cells to zoledronic acid can mediate osteonecrosis of jaw: an in vitro model. J Oral Pathol Med. 41, 788\u2013792 (2012).","journal-title":"J Oral Pathol Med."},{"key":"37063_CR39","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1007\/s00784-018-2349-6","volume":"22","author":"J Jung","year":"2018","unstructured":"Jung, J. et al. Effects of an oral bisphosphonate and three intravenous bisphosphonates on several cell types in vitro. Clin Oral Investig. 22, 2527\u20132534 (2018).","journal-title":"Clin Oral Investig."},{"key":"37063_CR40","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/j.1365-2141.2008.07504.x","volume":"144","author":"MA Scheper","year":"2009","unstructured":"Scheper, M. A., Badros, A., Chaisuparat, R., Cullen, K. J. & Meiller, T. F. Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis. Br J Haematol. 144, 667\u2013676 (2009).","journal-title":"Br J Haematol."},{"key":"37063_CR41","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3892\/mmr.2015.4627","volume":"13","author":"X Huang","year":"2016","unstructured":"Huang, X. et al. Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro. Mol Med Rep. 13, 613\u2013622 (2016).","journal-title":"Mol Med Rep."},{"key":"37063_CR42","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1159\/000351194","volume":"59","author":"FG Basso","year":"2013","unstructured":"Basso, F. G., Silveira-Turrioni, A. P., Hebling, J. & de-Souza-Costa, C. A. Zoledronic acid inhibits human osteoblast activities. Gerontology. 59, 534\u2013541 (2013).","journal-title":"Gerontology."},{"key":"37063_CR43","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/jop.12181","volume":"43","author":"S Zafar","year":"2014","unstructured":"Zafar, S. et al. Zoledronic acid and geranylgeraniol regulate cellular behaviour and angiogenic gene expression in human gingival fibroblasts. J Oral Pathol Med. 43, 711\u2013721 (2014).","journal-title":"J Oral Pathol Med."},{"key":"37063_CR44","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/j.1601-0825.2010.01720.x","volume":"17","author":"C Walter","year":"2011","unstructured":"Walter, C., Pabst, A., Ziebart, T., Klein, M. & Al-Nawas, B. Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro. Oral Dis. 17, 194\u2013199 (2011).","journal-title":"Oral Dis."},{"key":"37063_CR45","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1159\/000313876","volume":"47","author":"M Michailidou","year":"2010","unstructured":"Michailidou, M. et al. Microvascular endothelial cell responses in vitro and in vivo: modulation by zoledronic acid and paclitaxel? J Vasc Res. 47, 481\u2013493 (2010).","journal-title":"J Vasc Res."},{"key":"37063_CR46","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3892\/br.2013.145","volume":"1","author":"T Ziebart","year":"2013","unstructured":"Ziebart, T. et al. Investigation of inhibitory effects on EPC-mediated neovascularization by different bisphosphonates for cancer therapy. Biomed Rep. 1, 719\u2013722 (2013).","journal-title":"Biomed Rep."},{"key":"37063_CR47","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1159\/000347226","volume":"85","author":"D Santini","year":"2013","unstructured":"Santini, D. et al. Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. Oncology. 85, 342\u2013347 (2013).","journal-title":"Oncology."},{"key":"37063_CR48","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.tripleo.2011.02.028","volume":"112","author":"F Wehrhan","year":"2011","unstructured":"Wehrhan, F. et al. Differential impairment of vascularization and angiogenesis in bisphosphonate-associated osteonecrosis of the jaw-related mucoperiosteal tissue. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 112, 216\u2013221 (2011).","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod."},{"key":"37063_CR49","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.oraloncology.2011.12.004","volume":"48","author":"M Mozzati","year":"2012","unstructured":"Mozzati, M., Gallesio, G., Arata, V., Pol, R. & Scoletta, M. Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32 cases. Oral Oncol. 48, 469\u2013474 (2012).","journal-title":"Oral Oncol."},{"key":"37063_CR50","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/jor.21073","volume":"28","author":"E Cenni","year":"2010","unstructured":"Cenni, E., Avnet, S., Fotia, C., Salerno, M. & Baldini, N. Platelet-rich plasma impairs osteoclast generation from human precursors of peripheral blood. J Orthop Res. 28, 792\u2013797 (2010).","journal-title":"J Orthop Res."},{"key":"37063_CR51","first-page":"729","volume":"41","author":"D Wang","year":"2018","unstructured":"Wang, D. et al. Platelet-rich plasma inhibits RANKL-induced osteoclast differentiation through activation of Wnt pathway during bone remodeling. Int J Mol Med. 41, 729\u2013738 (2018).","journal-title":"Int J Mol Med."},{"key":"37063_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/srep46322","volume":"7","author":"M Morita","year":"2017","unstructured":"Morita, M. et al. Elevation of pro-inflammatory cytokine levels following anti-resorptive drug treatment is required for osteonecrosis development in infectious osteomyelitis. Sci Rep. 7, 46322 (2017).","journal-title":"Sci Rep."},{"key":"37063_CR53","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.oooo.2014.04.017","volume":"118","author":"E Franco-Pretto","year":"2014","unstructured":"Franco-Pretto, E., Pacheco, M., Moreno, A., Messa, O. & Gnecco, J. Bisphosphonate-induced osteonecrosis of the jaws: clinical, imaging, and histopathology findings. Oral Surg Oral Med Oral Pathol. Oral Radiol. 118, 408\u2013417 (2014).","journal-title":"Oral Radiol."},{"key":"37063_CR54","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.oooo.2013.03.001","volume":"115","author":"K Anavi-Lev","year":"2013","unstructured":"Anavi-Lev, K. et al. Bisphosphonate related osteonecrosis of the jaws: clinico-pathological investigation and histomorphometric analysis. Oral Surg Oral Med Oral Pathol. Oral Radiol. 115, 660\u2013666 (2013).","journal-title":"Oral Radiol."},{"key":"37063_CR55","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00428-007-0516-2","volume":"451","author":"T Hansen","year":"2007","unstructured":"Hansen, T. et al. Actinomycosis of the jaws\u2014histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis. Virchows Arch. 451, 1009\u20131017 (2007).","journal-title":"Virchows Arch."},{"key":"37063_CR56","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jcms.2017.01.006","volume":"45","author":"S Panya","year":"2017","unstructured":"Panya, S. et al. Role of microbiological culture and polymerase chain reaction (PCR) of actinomyces in medication-related osteonecrosis of the jaw (MRONJ). J Craniomaxillofac Surg. 45, 357\u2013363 (2017).","journal-title":"J Craniomaxillofac Surg."},{"key":"37063_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/srep31604","volume":"6","author":"G Russmueller","year":"2016","unstructured":"Russmueller, G. et al. The association of medication-related osteonecrosis of the jaw with Actinomyces spp. infection. Sci Rep. 6, e.31604 (2016).","journal-title":"Sci Rep."},{"key":"37063_CR58","doi-asserted-by":"publisher","first-page":"e.47","DOI":"10.1186\/1471-2180-13-47","volume":"13","author":"L Drago","year":"2013","unstructured":"Drago, L., Bortolin, M., Vassena, C., Taschieri, S. & Del Fabbro, M. Antimicrobial activity of pure platelet-rich plasma against microorganisms isolated from oral cavity. BMC Microbiol. 13, e.47 (2013).","journal-title":"BMC Microbiol."},{"key":"37063_CR59","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.jcms.2015.04.026","volume":"43","author":"P Barba-Recreo","year":"2015","unstructured":"Barba-Recreo, P. et al. Adipose-derived stem cells and platelet-rich plasma for preventive treatment of bisphosphonate-relatedosteonecrosis of the jaw in a murine model. J Craniomaxillofac Surg. 43, 1161\u20131168 (2015).","journal-title":"J Craniomaxillofac Surg."},{"key":"37063_CR60","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/cid.12361","volume":"18","author":"MD Jovani-Sancho","year":"2015","unstructured":"Jovani-Sancho, M. D., Sheth, C. C., Marqu\u00e9s-Mateo, M. & Puche-Torres, M. Platelet-rich plasma: a study of the variables that may influence its effect on bone regeneration. Clin Implant Dent Relat Res. 18, 1051\u20131064 (2015).","journal-title":"Clin Implant Dent Relat Res."},{"key":"37063_CR61","doi-asserted-by":"publisher","first-page":"e.17196","DOI":"10.5812\/traumamon.17196","volume":"19","author":"F Sarkarat","year":"2014","unstructured":"Sarkarat, F. et al. Platelet-rich plasma in treatment of zoledronic acid-induced bisphosphonate-related osteonecrosis of the jaws. Trauma Mon. 19, e.17196 (2014).","journal-title":"Trauma Mon."},{"key":"37063_CR62","first-page":"e.298945","volume":"2014","author":"F Longo","year":"2012","unstructured":"Longo, F. et al. Platelet rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw: personal experience and review of the literature. Int J Dent. 2014, e.298945 (2012).","journal-title":"Int J Dent."},{"key":"37063_CR63","first-page":"151","volume":"26","author":"V Coviello","year":"2012","unstructured":"Coviello, V. et al. Pratelet-rich plasma improves wound healing in multiple myeloma bisphosphonate-associated osteonecrosis of the jaw patients. J Biol Regul Homeost Agents. 26, 151\u2013155 (2012).","journal-title":"J Biol Regul Homeost Agents."},{"key":"37063_CR64","first-page":"e253","volume":"168","author":"M Capocci","year":"2017","unstructured":"Capocci, M. et al. Medication-related osteonecrosis of the jaws (MRONJ) and quality of life evolution: a pilot study. Clin Ter. 168, e253\u2013e257 (2017).","journal-title":"Clin Ter."},{"key":"37063_CR65","unstructured":"Canadian Council on Animal Care. Guide to Care and Use of Experimental Animals, vol 1, 2nd edition. Available at, https:\/\/www.ccac.ca\/Documents\/Standards\/Guidelines\/Experimental_Animals_Vol1.pdf (acessed nov. 2018)."},{"key":"37063_CR66","doi-asserted-by":"publisher","first-page":"e:1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M. & Altman, D. G. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PloS Biol. 8, e:1000412 (2010).","journal-title":"PloS Biol."},{"key":"37063_CR67","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jphotobiol.2018.05.004","volume":"84","author":"C Statkievicz","year":"2018","unstructured":"Statkievicz, C. et al. Photomodulation multiple sessions as a promising preventive therapy for medication-related osteonecrosis of the jaws after tooth extraction in rats. J Photochem Photobiol B. 84, 7\u201317 (2018).","journal-title":"J Photochem Photobiol B."},{"key":"37063_CR68","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bone.2018.10.014","volume":"120","author":"E Ervolino","year":"2018","unstructured":"Ervolino, E. et al. Antimicrobial photodynamic therapy improves the alveolar repair process and prevents the occurrence of osteonecrosis of the jaws after tooth extraction in senile rats treated with zoledronate. Bone. 120, 101\u2013113 (2019).","journal-title":"Bone."},{"key":"37063_CR69","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.archoralbio.2015.05.015","volume":"60","author":"PG Silva","year":"2015","unstructured":"Silva, P. G. et al. Effect of different doses of zoledronic acid in establishing of bisphosphonate related osteonecrosis. Arch. Oral Biol. 60, 1237\u20131245 (2015).","journal-title":"Arch. Oral Biol."},{"key":"37063_CR70","first-page":"879","volume":"15","author":"D Sonnleitner","year":"2000","unstructured":"Sonnleitner, D., Huemer, P. & Sullivan, D. Y. A simplified technique for producing platelet-rich plasma and platelet concentrate for intraoral bone grafting techniques: a technical note. Int J Oral Maxillofac Implants. 15, 879\u2013882 (2000).","journal-title":"Int J Oral Maxillofac Implants."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37063-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37063-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37063-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T04:40:03Z","timestamp":1671252003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37063-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,10]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["37063"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-37063-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,10]]},"assertion":[{"value":"24 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"22"}}